tiprankstipranks
Advertisement
Advertisement

Tristel Delivers Strong First Half as CEO Plans Exit for US Role

Story Highlights
  • Tristel posted double-digit H1 revenue and EBITDA growth, preserved high margins, and ended the period debt-free with a solid cash position.
  • CEO Matt Sassone will step down at year-end for a US multinational role, with the board stressing leadership depth and an ongoing search for his successor.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Tristel Delivers Strong First Half as CEO Plans Exit for US Role

Claim 30% Off TipRanks

Tristel ( (GB:TSTL) ) has issued an announcement.

Tristel reported a strong first half to the financial year ended 31 December 2025, with revenues up 14%, adjusted EBITDA rising 17%, gross margins maintained at 81% and EBITDA margins reaching 28%, while remaining debt-free with £13.3m in cash and US revenue growth tracking internal forecasts. Alongside the upbeat trading update, the company announced the planned departure of Chief Executive Officer Matt Sassone at the end of the financial year as he moves to a senior role at a large US multinational, with the board emphasizing management depth, an unchanged growth strategy and an active search for a new CEO to sustain operational momentum and support its investment case.

The most recent analyst rating on (GB:TSTL) stock is a Buy with a £478.00 price target. To see the full list of analyst forecasts on Tristel stock, see the GB:TSTL Stock Forecast page.

Spark’s Take on GB:TSTL Stock

According to Spark, TipRanks’ AI Analyst, GB:TSTL is a Outperform.

Tristel’s strong financial performance and positive earnings call outlook are the primary drivers of its stock score. While technical indicators suggest caution due to overbought conditions, the company’s strategic expansion and dividend increase support a favorable long-term view. Valuation concerns are mitigated by the company’s growth prospects.

To see Spark’s full report on GB:TSTL stock, click here.

More about Tristel

Tristel plc is a global infection prevention company specialising in proprietary chlorine dioxide-based chemistry for the manual decontamination of medical devices and sporicidal surface disinfection. Operating from its head office and manufacturing facility near Cambridge, the AIM-listed group supplies hospitals worldwide under the Tristel and Cache brands, employs around 270 staff across 16 subsidiaries, and sells into more than 40 countries with a strategic focus on double-digit revenue growth, robust cash generation and progressive dividends.

Average Trading Volume: 201,802

Technical Sentiment Signal: Strong Buy

Current Market Cap: £189M

Learn more about TSTL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1